Tinea Cruris

13 clinical trials · Condition

Record	Firm	Date
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (NCT05363449)	Therapeutics, Inc.	2022-02-17
Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris (NCT02767271)	Bausch Health Americas, Inc.	2015-12-02
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris (NCT02394340)	Bausch & Lomb Incorporated	2015-02-03
Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris (NCT03359070)	Galeno Desenvolvimento de Pesquisas Clínicas	2014-01-29
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris (NCT01885156)	Merz North America, Inc.	2013-08-01
Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis (NCT01712360)	Merz North America, Inc.	2012-10-01
Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections (NCT01105013)	Laboratório Teuto Brasileiro S/A	2012-04-01
Topical Antifungal Treatment for Tinea Cruris (NCT01342315)	Medicis Global Service Corporation	2011-05-01
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis (NCT01349998)	Tinea Pharmaceuticals	2011-05-01
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris (NCT00750152)	Merz North America, Inc.	2008-09-01

Every clearance here is in the API, with alerts when new ones post.